Please assess the completion status of the following clinical trial:

Trial Title: Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All pre-terms ( \< 37 weeks of gestational age.)~* Within the first 7 days postnatal days (\</=168 hours).~* Clinically stable from respiratory, hemodynamic and metabolic point of view.~* Who have not received any painful stimulus at least 30 minutes prior to the intervention.~* Requiring routine orogastric tube insertion within the first 7 days of life.~* Only the first attempt at putting OGT in controlled NICU environment will be considered~Exclusion Criteria:~The neonates with the following characteristics will be excluded from the study:~* Neonates requiring ventilatory support.~* Neonates requiring oxygen supplementation.~* Having any facial congenital anomalies.~* Having any neurological impairment.~* Receiving opiates or born to mothers receiving opiates.~* New born babies to whom muscle relaxants, sedatives and analgesics have been administered.~* With grade 3 and 4 IVH.~* With major congenital anomalies~* Any history of birth trauma especially involving face or scalp (including cephalhematoma/ subgaleal bleed).~* Face presentation.

- Gender: ALL
- Minimum Age: 1 Hour
- Maximum Age: 167 Hours
- Healthy Volunteers: f

Study Arms:
- Sucrose (Type: ACTIVE_COMPARATOR): 1 ml of 24% sucrose was administered 2 minutes before the procedure
- Placebo (Type: PLACEBO_COMPARATOR): Double distilled water

Based on this trial design, predict the completion outcome and termination type (if applicable).